Danaher Corporation $DHR Stake Lifted by Vestmark Advisory Solutions Inc.

Key Points

• Vestmark Advisory Solutions Inc. increased its stake in Danaher Corporation by 62.3% during Q1, now holding 13,238 shares valued at approximately $2.71 million.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Danaher, with target prices ranging from $226.00 to $250.00.
• Danaher reported a Q2 earnings per share of $1.80, exceeding expectations and reflecting a 3.4% increase in revenue year-over-year.

Vestmark Advisory Solutions Inc. grew its stake in Danaher Corporation (NYSE:DHR - Free Report) by 62.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 13,238 shares of the conglomerate's stock after purchasing an additional 5,080 shares during the period. Vestmark Advisory Solutions Inc.'s holdings in Danaher were worth $2,714,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. FAS Wealth Partners Inc. boosted its position in Danaher by 20.6% in the 4th quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock valued at $2,203,000 after buying an additional 1,639 shares during the last quarter. MGO One Seven LLC grew its holdings in shares of Danaher by 485.7% in the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock valued at $5,145,000 after acquiring an additional 20,813 shares in the last quarter. Asahi Life Asset Management CO. LTD. bought a new position in shares of Danaher in the 1st quarter valued at about $539,000. Horizon Financial Services LLC grew its holdings in Danaher by 20,400.0% during the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock worth $1,681,000 after purchasing an additional 8,160 shares during the period. Finally, EFG Asset Management Americas Corp. lifted its position in Danaher by 13.1% during the first quarter. EFG Asset Management Americas Corp. now owns 36,080 shares of the conglomerate's stock worth $7,396,000 after acquiring an additional 4,191 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Price Performance

Shares of NYSE:DHR traded down $4.0980 during midday trading on Thursday, hitting $207.3020. 704,886 shares of the stock were exchanged, compared to its average volume of 4,212,528. The stock has a market cap of $148.44 billion, a P/E ratio of 44.12, a PEG ratio of 2.96 and a beta of 0.73. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.90. The company has a 50 day moving average price of $200.46 and a 200-day moving average price of $199.62.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the previous year, the company posted $1.72 EPS. The business's revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on DHR shares. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target for the company in a research report on Friday, July 11th. Guggenheim reaffirmed a "buy" rating and set a $250.00 target price on shares of Danaher in a research note on Wednesday, July 23rd. Wall Street Zen upgraded shares of Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Finally, TD Cowen upped their price objective on shares of Danaher from $240.00 to $248.00 and gave the stock a "buy" rating in a research report on Wednesday, April 23rd. Seventeen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $247.61.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.